Paper19757204
Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy.
Feng G and 7 others. J Mol Neurosci, 2009. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. Papers, record 19757204. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19757204
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Down-Regulation | Major topic |
| Epilepsy | Major topic |
| Membrane Glycoproteins | Major topic |
| Neocortex | Major topic |
| Nerve Tissue Proteins | Major topic |
| Temporal Lobe | Major topic |
| Adolescent | |
| Adult | |
| Biomarkers | |
| Blotting, Western | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immunochemistry | |
| Male | |
| Middle Aged | |
| Neurons | |
| Young Adult |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15946327 | Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. | Epilepsia | 2005 | https://conductscience.org/library/papers/15946327 | PubMed |
| 2 | 12644749 | Mechanisms of antiepileptic drug resistance. | Curr Opin Neurol | 2003 | https://conductscience.org/library/papers/12644749 | PubMed |
| 3 | 18717715 | Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. | Epilepsia | 2009 | https://conductscience.org/library/papers/18717715 | PubMed |
| 4 | 19220410 | Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. | Epilepsia | 2009 | https://conductscience.org/library/papers/19220410 | PubMed |
| 5 | 19176798 | SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. | J Neurosci | 2009 | https://conductscience.org/library/papers/19176798 | PubMed |
| 6 | 15210974 | The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15210974 | PubMed |
| 7 | 10624962 | SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. | Neuron | 1999 | https://conductscience.org/library/papers/10624962 | PubMed |
| 8 | 17199025 | Seletracetam (UCB 44212). | Neurotherapeutics | 2007 | https://conductscience.org/library/papers/17199025 | PubMed |
| 9 | 10660394 | Early identification of refractory epilepsy. | N Engl J Med | 2000 | https://conductscience.org/library/papers/10660394 | PubMed |
| 10 | 17199019 | Brivaracetam (UCB 34714). | Neurotherapeutics | 2007 | https://conductscience.org/library/papers/17199019 | PubMed |
| 11 | 15208697 | The neurobiology of antiepileptic drugs. | Nat Rev Neurosci | 2004 | https://conductscience.org/library/papers/15208697 | PubMed |
| 12 | 8083732 | Differential expression of synaptic vesicle protein 2 (SV2) isoforms. | J Neurosci | 1994 | https://conductscience.org/library/papers/8083732 | PubMed |
| 13 | 18779938 | Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy. | J Mol Neurosci | 2009 | https://conductscience.org/library/papers/18779938 | PubMed |
| 14 | 10611374 | Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10611374 | PubMed |
| 15 | 2579958 | Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. | J Cell Biol | 1985 | https://conductscience.org/library/papers/2579958 | PubMed |
| 16 | 16556440 | Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16556440 | PubMed |
| 17 | 2233919 | The evaluation and treatment of seizures. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2233919 | PubMed |
| 18 | 10210025 | Clinical aspects and biological bases of drug-resistant epilepsies. | Epilepsy Res | 1999 | https://conductscience.org/library/papers/10210025 | PubMed |
| 19 | 10625067 | SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. | Neuroscience | 1999 | https://conductscience.org/library/papers/10625067 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41528802 | Higher drinking frequency corresponds to lower synaptic density in people with alcohol use disorder. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41528802 | PubMed |
| 40878444 | Targeting ROCK2 to Restore Epileptic Synaptic Networks via Mitophagy Activation: Insights from Translational Imaging of SV2A In Vivo. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40878444 | PubMed |
| 40016536 | Single-Cell Analysis of Sex and Gender Differences in the Human Brain During Development and Disease. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40016536 | PubMed |
| 39777496 | Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy. | Eur J Nucl Med Mol Imaging | 2025 | https://conductscience.org/library/papers/39777496 | PubMed |
| 36313347 | Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36313347 | PubMed |
| 35686059 | Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/35686059 | PubMed |
| 35578248 | Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE). | Mol Brain | 2022 | https://conductscience.org/library/papers/35578248 | PubMed |
| 35573314 | Synaptic Vesicle Glycoprotein 2A: Features and Functions. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35573314 | PubMed |
| 34435329 | Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/34435329 | PubMed |
| 33922424 | Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment. | Brain Sci | 2021 | https://conductscience.org/library/papers/33922424 | PubMed |
| 32514885 | Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain. | Mol Imaging Biol | 2020 | https://conductscience.org/library/papers/32514885 | PubMed |
| 32206990 | Exploring with [18F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. | Mol Imaging Biol | 2020 | https://conductscience.org/library/papers/32206990 | PubMed |
| 31818018 | Synaptic Pruning by Microglia in Epilepsy. | J Clin Med | 2019 | https://conductscience.org/library/papers/31818018 | PubMed |
| 31659510 | Current radiotracers to image neurodegenerative diseases. | EJNMMI Radiopharm Chem | 2019 | https://conductscience.org/library/papers/31659510 | PubMed |
| 31394034 | The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/31394034 | PubMed |
| 31209780 | Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue. | Mol Imaging Biol | 2020 | https://conductscience.org/library/papers/31209780 | PubMed |
| 31175396 | Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A). | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/31175396 | PubMed |
| 31166988 | Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression. | PLoS One | 2019 | https://conductscience.org/library/papers/31166988 | PubMed |
| 30949562 | Sex differences in stress-related alcohol use. | Neurobiol Stress | 2019 | https://conductscience.org/library/papers/30949562 | PubMed |
| 30121895 | Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue. | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/30121895 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SV2A | 9900 | PubTator's text mining | https://conductscience.org/library/genes/9900 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19757204
GET https://conductscience.org/api/papers/v1/19757204/cited_by?page=2